Veterinary Medicines

Nobilis IB+ND+EDS emulsion for injection

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis IB+ND+EDS emulsion for injection
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    6.00
    haemagglutinating units
    /
    1.00
    Dose
  • Newcastle disease virus, strain Clone 30, Inactivated
    4.00
    haemagglutinating units
    /
    1.00
    Dose
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
    6.50
    haemagglutinating units
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Eggs
        0
        day
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken
      • Eggs
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Cardboard box containing a PET bottle with 500 ml (1,000 doses) of the vaccine.The bottles are closed with a nitryl rubber stopper and sealed with a coded aluminium cap

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/094/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."